Skip to main content

BrainsWay Ltd.

corporate_fare Company Profile

BrainsWay Ltd.

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Exchange: NASDAQSector: Industrial Applications And Services

show_chartPrice Chart

Loading chart...

feed BWAY - Latest Insights

BWAY
Apr 20, 2026, 4:01 PM EDT
Filing Type: 20-F
Importance Score:
8
BWAY
Apr 15, 2026, 7:30 AM EDT
Filing Type: 6-K
Importance Score:
8
BWAY
Mar 26, 2026, 7:30 AM EDT
Filing Type: 6-K
Importance Score:
8
BWAY
Mar 11, 2026, 7:30 AM EDT
Filing Type: 6-K
Importance Score:
8
BWAY
Mar 05, 2026, 6:00 AM EST
Filing Type: 6-K
Importance Score:
8
BWAY
Feb 19, 2026, 7:30 AM EST
Filing Type: 6-K
Importance Score:
7
BWAY
Feb 18, 2026, 7:30 AM EST
Filing Type: 6-K
Importance Score:
8
BWAY
Jan 21, 2026, 7:30 AM EST
Filing Type: 6-K
Importance Score:
8
BWAY
Jan 12, 2026, 7:30 AM EST
Filing Type: 6-K
Importance Score:
9
BWAY
Jan 07, 2026, 7:30 AM EST
Filing Type: 6-K
Importance Score:
8